Assessment of healthcare resource utilization and direct medical cost in relation to treatment length of oral corticosteroids in biologic-initiated patients with ulcerative colitis: a Japanese claims database study
Biologic initiation was associated with reduced HCRU and inpatient costs, with similar trends observed regardless of prolonged or shorter OC use duration.
Authors
- Shinichi Yoshigoe (ORCID: https://orcid.org/0000-0003-2704-054X)
- Celine Miyazaki (ORCID: https://orcid.org/0000-0002-0224-563X)
- Nan Li (ORCID: https://orcid.org/0000-0002-2932-9649)
- Shinya Sugimoto (ORCID: https://orcid.org/0000-0002-1560-1605)
- Tomoyuki Inoue (ORCID: https://orcid.org/0000-0002-1999-9526)
Institutions
- Johnson & Johnson (United States) (US)
- Johnson & Johnson (Brazil) (BR)
Publication Details
- Journal
- Journal of Medical Economics
- Published
- 2025-09-04
- DOI
- https://doi.org/10.1080/13696998.2025.2555138
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00